HUTCHMED (China) (HCM) Capital Expenditures (2018 - 2021)
HUTCHMED (China)'s (HCM) quarterly Capital Expenditures came in at -$2.9 million in Q2 2021, down 44.95% year-on-year from -$5.2 million in Q2 2020, and up 52.83% on a QoQ basis from -$6.1 million in Q1 2021.
HUTCHMED (China) (HCM) Capital Expenditures (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Capital Expenditures data on file, last reported at -$2.9 million in Q2 2021.
- On a quarterly basis, Capital Expenditures fell 44.95% year-over-year to -$2.9 million in Q2 2021; TTM through Jun 2021 was -$13.0 million, a 1611.89% decrease from a year earlier, with the FY2025 full-year figure at -$4.2 million, up 44.01% from the prior year.
- Capital Expenditures for Q2 2021 stood at -$2.9 million, up from -$6.1 million in the prior quarter.
- Over the last five years, Capital Expenditures for HCM reached as high as $6.7 million in Q4 2019 and fell as low as -$6.1 million in Q1 2021.
- Historically, Capital Expenditures has averaged -$980500.0 across 4 years, with a median of -$1.6 million in 2019.
- On a YoY basis, Capital Expenditures climbed as much as 87.12% in 2019 and fell as far as 226.81% in 2019.
- Year by year, Capital Expenditures stood at $3.6 million in 2018, then surged by 87.12% to $6.7 million in 2019, then plunged by 129.5% to -$2.0 million in 2020, then sank by 44.95% to -$2.9 million in 2021.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$2.9 million in Q2 2021, -$6.1 million in Q1 2021, and -$2.0 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -2.86 Mn |
| Jun 30, 2021 | -2.86 Mn |
| Mar 31, 2021 | -6.06 Mn |
| Mar 31, 2021 | -6.06 Mn |
| Jun 30, 2020 | -1.97 Mn |
| Jun 30, 2020 | -1.97 Mn |
| Mar 31, 2020 | -2.09 Mn |
| Mar 31, 2020 | -2.09 Mn |
| Dec 31, 2019 | 6.68 Mn |
| Dec 31, 2019 | 6.68 Mn |
| Sep 30, 2019 | -1.77 Mn |
| Sep 30, 2019 | -1.77 Mn |
| Jun 30, 2019 | -2.49 Mn |
| Jun 30, 2019 | -2.49 Mn |
| Mar 31, 2019 | -1.36 Mn |
| Mar 31, 2019 | -1.36 Mn |
| Dec 31, 2018 | 3.57 Mn |
| Dec 31, 2018 | 3.57 Mn |
| Sep 30, 2018 | -1.35 Mn |
| Sep 30, 2018 | -1.35 Mn |